ANASALVA vs PANDA MOBILE

Anasalva is a medical and health reference platform designed to provide organized, up-to-date, and easy-to-explore information for healthcare professionals, students, and users interested in learning more about health-related topics. The app brings together 150 features covering areas such as medications, active ingredients, drug interactions, diseases, diagnostic tests, laboratory values, radiology, clinical scales, anatomy, microbiology, vaccines, nutrition, emergencies, vital signs, digital health records, and practical tools for personal and family health tracking. With Anasalva, you can: • Access information on medications, active ingredients, antibiotics, pharmacological categories, ATC codes, RX/OTC classification, therapeutic equivalence, RxNorm, LOINC, and essential medicines. • Review interactions between medications, active ingredients, and foods, including risk levels, alerts, and informational alternatives. • Explore content on diseases, ICD-10, ICD-11, specialty-based conditions, infectious agents, viruses, bacteria, fungi, protozoa, helminths, arthropods, and vectors. • Consult laboratory parameters and profiles, medical tests, diagnostic procedures, ultrasounds, mammograms, biopsies, MRI, nuclear medicine, angiography, and special radiographic views. • Use health tools such as growth percentiles, psychomotor development, estimated final height, glomerular filtration, nephrology equations, vital signs, unit converter, glucose tracker, medication reminders, and insurance card storage. • Organize personal or family health information through the Digital Health Record, designed to help users keep relevant data in one place and support better communication with healthcare professionals. • Explore resources on nutrition, foods, vitamins, medicinal plants, natural remedies, additives, health tips, emergencies, and first aid. • Access learning and preparation modules, including exams for physicians, nurses, psychologists, visual diagnosis, biological pathogens, and orthopedics and traumatology. • Search content quickly using general search, favorites, medical repository, medical literature, biomedical images, medical directory, chat, and notifications. Anasalva is available in 10 languages: Spanish, English, French, Italian, Portuguese, Russian, German, Chinese, Arabic, and Hindi. Its goal is to provide a practical, portable, and accessible experience with useful information for study, research, data verification, and better understanding of medical indications, treatments, tests, and preventive measures. The app is intended for general practitioners, specialists, residents, health technology professionals, technicians, students, healthcare personnel, and users who want an informative tool to support their understanding of health and family care. Important notice: Anasalva is an informational and educational tool. It does not replace clinical judgment, diagnosis, treatment, or care provided by a qualified healthcare professional. The information included in the app should be used as a reference for consultation, learning, and verification, not as a substitute for a personalized medical evaluation. If you have symptoms, questions about treatments, medications, interactions, emergencies, or health decisions, always consult a qualified healthcare professional. Anasalva does not provide personalized professional medical advice and does not recommend specific products, treatments, or medications. Use of the information is the responsibility of the user. For more information you can consult our Privacy Policy and Terms of Use at: • https://www.anasalva.org/politica-privacidad/ • https://www.anasalva.org/condiciones-generales-de-uso/ • https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

PANDA MOBILE App allows us to collect video data of infants between 1 and 6 months old. We will analyze the videos using state of the art algorithms to build screening tools that can be used in life by lay clinicians and caregivers. The study’s goal is to develop an affordable non-invasive easy-to-use tool for early detection of infant neurodevelopmental disabilities so they can receive treatment at an early age. Significance: In the USA, 1 in 10 infants are born at risk for these disabilities. Early treatment in the first year of life improves long-term outcomes. Today’s clinical tests are however less than adequate. Hard to administer, they require specialized training, and have limited long-term predictive value. There is a critical need for an objective, accurate, easy-to-use tool for early prediction of long-term physical disability. This project’s goal is to develop an automated assessment for early and accurate detection of infants at risk for neurodevelopmental disabilities by capitalizing on state of the art sensing and machine learning technologies. Our project will bring us closer to a universal non-invasive test for early detection of neurodevelopmental disabilities. This test will scale to infants worldwide, producing an affordable tool for infant health assessment. Objectives: Our project has three aims. This effort focuses on aim 2 which is to populate a database of infant videos. We aim to collect at least 1200 unique infant videos (400 with early brain injury, 400 preterm without early brain injury, 400 controls). From the videos we will develop a computer vision algorithm to quantify infant motor performance. Funding: Our project is being funded by the National Institutes of Health – National Institutes of Child Health and Development: R01- HD-097686. We are in partnership with AngelEye Health, a leader in developing cameras for the NICU and monitoring infants."